<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 12b-25
NOTIFICATION OF LATE FILING
(Check one): __ Form 10-KSB __ Form 20-F X Form 10-QSB __ Form N-SAR
---
For period ended: September 30, 2000
[ ] Transition Report on Form 10-K and Form 10-KSB [ ]
Transition Report on Form 20-F [ ] Transition Report on Form
11-K [ ] Transition Report on Form 10-Q and Form 10-QSB [ ]
Transition Report on Form N-SAR For the transition period
ended
SEC File Number 2-93277-D
CUSIP Number - 58501310
Nothing in this form shall be construed to imply that the Commission has
verified any information contained herein.
If the notification relates to a portion of the filing checked above, identify
the item(s) to which the notification relates:__________________________________
PART I-REGISTRANT INFORMATION
MEDIZONE INTERNATIONAL, INC.
--------------------------------------
Full Name of Registrant
144 Buena Vista
Stinson Beach, CA 94970
(415) 868-0300
--------------------------------------
Address and telephone number of
principal executive office
1
<PAGE>
PART II-RULES 12b-25(b) AND (c)
If the subject report could not be filed without unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following should
be completed. (Check appropriate box)
[ ] (a) The reasons described in reasonable detail in Part III of this
form could not be eliminated without unreasonable effort or
expense;
[X] (b) The subject annual report, semi-annual report, transition
report on Forms 10-K, 10-KSB, 20-F, 11-K, or Form N-SAR, or
portion thereof will be filed on or before the 15th calendar
day following the prescribed due date; or the subject
quarterly report or transition report on Form 10-Q, 10-QSB, or
portion thereof will be filed on or before the fifth calendar
day following the prescribed due date; and
[ ] (c) The accountant's statement or other exhibit required by Rule
12b-25(c) has been attached if applicable.
PART III-NARRATIVE
State below in reasonable detail the reasons why the Form 10-K, 10-KSB,
11-K, 20-F, 10-Q, 10-QSB, N-SAR or the transition report portion thereof, could
not be filed within the prescribed time period.
The quarterly report of the registrant on Form 10-QSB could not be
filed because management requires additional time to compile and verify the data
required to be included in the report.
PART IV-OTHER INFORMATION
(1) Name and telephone number of person to contact in regard to this
notification.
Kevin R. Andersen (801) 486-0096
(Name) (Area Code) (Telephone Number)
(2) Have all other periodic reports required under Section 13 or 15(d) or the
Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of
1940 during the preceding 12 months (or for such shorter period that the
registrant was required to file such report(s)) been filed? If the answer is no,
identify report(s).
X Yes __ No
2
<PAGE>
(3) Is it anticipated that any significant change in results of operations from
the corresponding period for the last fiscal year will be reflected by the
earnings statements to be included in the subject report or portion thereof?
__ Yes X No
---
If so: attach an explanation of the anticipated change, both narratively and
quantitatively, and, if appropriate, state the reasons why a reasonable estimate
of the results cannot be made.
MEDIZONE INTERNATIONAL, INC.
-------------------------------------------
(Name of Registrant as Specified in Charter)
has caused this notification to be signed on its behalf by the undersigned
thereunto duly authorized.
_____________________________ATTENTION_________________________________________
INTENTIONAL MISSTATEMENTS OR OMISSIONS OR FACT CONSTITUTE FEDERAL
CROMINAL VIOLOATIONS (SEE 18 U.S.C.1001)
Date November 15, 2000 By: /s/ Edwin G. Marshall
---------------------------------
Edwin G. Marshall, CEO
3
